Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-25T07:41:45.406Z Has data issue: false hasContentIssue false
  • English
  • Français

A Comment on the Role of Environmental Factors in Parkinson's Disease

Published online by Cambridge University Press:  02 December 2014

Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Canadian Journal of Neurological Sciences , Volume 37 , Issue 5 , September 2010 , pp. 555 - 556
Copyright
Copyright © The Canadian Journal of Neurological 2010

References

1. Sanyal, J, Chakraborty, DP, Sarkar, B, et al. Environmental and familial risk factors of Parkinsons disease: case control study. Can J Neurol Sci. 2010;37(5):637–42.Google Scholar
2. Cicchetti, F, Drouin-Ouellet, J, Gross, RE. Environmental toxins and Parkinson’s disease: what have we learned from pesticide-induced animal models? Trends Pharmacol Sci. 2009;30(9):475–83.Google Scholar
3. Mangano, EN, Hayley, S. Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: neuroimmune sensitization of neurodegeneration. Neurobiol Aging. 2009;30(9):1361–78.Google Scholar
4. Liu, B, Gao, HM, Hong, JS. Parkinson’s disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ Health Perspect. 2003;111(8):1065–73.Google Scholar
5. Peng, J, Peng, L, Stevenson, FF, Doctrow, SR, Andersen, JK. Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson’s disease accelerate age-related neurodegeneration. J Neurosci. 2007;27(26):6914–22.Google Scholar
6. Costello, S, Cockburn, M, Bronstein, J, Zhang, X, Ritz, B. Parkinson’s disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am J Epidemiol. 2009;169(8):919–26.Google Scholar
7. Yang, W, Chen, L, Ding, Y, Zhuang, X, Kang, UJ. Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice. Hum Mol Genet. 2007;16(23):2900–10.Google Scholar
8. Nuytemans, K, Theuns, J, Cruts, M, Van Broeckhoven, C. Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum Mutat. Epub 2010 May 18.Google Scholar
9. Reijnders, JS, Ehrt, U, Weber, WE, Aarsland, D, Leentjens, AF. A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord. 2008;23(2):183–9.Google Scholar
10. Burke, RE, Dauer, WT, Vonsattel, JP. A critical evaluation of the Braak staging scheme for Parkinson’s disease. Ann Neurol. 2008;64(5):485–91.CrossRefGoogle ScholarPubMed
11. Rommelfanger, KS, Edwards, GL, Freeman, KG, Liles, LC, Miller, GW, Weinshenker, D. Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice. Proc Natl Acad Sci USA. 2007;104(34):13804–9.Google Scholar